Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Microscopic Retinal Structure in Macular Telangiectasia

Austin Roorda; Brandon Lujan; Kavitha Ratnam; Vincent Liu; Johnny Tam; Steven Schwartz; Andrew Kaines; Paul Bernstein; Yuhua Zhang; Jacque Duncan

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3606.

ARVO Annual Meeting Abstract April 2011

Exploring Parameters That May Be Associated With The Efficacy Of Response To Intravitreal Bevacizumab (ivB) In A Two-year Prospective Randomised Trial Comparing ivB With Laser Therapy In The Management Of Diabetic Macular Oedema (BOLT Study)

Michel Michaelides; Simona Esposti; Ranjan Rajendram; Robin Hamilton; Andrew Kaines; Samantha Fraser-Bell; Cathy Egan; Tunde Peto; Catey Bunce; Phil Hykin

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5334.

ARVO Annual Meeting Abstract April 2010

Normative Data for Macular Thickness and Volume Measurements Using Cirrus HD-Optical Coherence Tomography

A. Y. Hu; T. Liu; A. Kaines; F. Yu; S. D. Schwartz; J. Hubschman

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):338.

ARVO Annual Meeting Abstract April 2010

Prospective Randomised Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study) - 12 Month Data

R. D. Hamilton; M. Michaelides; A. Kaines; S. Fraser-Bell; C. Egan; T. Peto; P. Hykin

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5846.

ARVO Annual Meeting Abstract April 2009

Utility of Ultra Wide Field Fluorescein Angiography in Evaluation and Management of Uveitis

A. Kaines; I. Tsui; D. Sarraf; S. D. Schwartz

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3573.

ARVO Annual Meeting Abstract April 2009

Catastrophic Visual Loss Following Sutureless 23-gauge Pars Plana Vitrectomy From Aminoglyciside Toxicity

S. P. Shah; A. Kaines; S. Reddy; S. D. Schwartz

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4207.

ARVO Annual Meeting Abstract April 2009

Macular Perfusion Determined by Fundus Fluorescein Angiography at the 4 Month Time Point in a Prospective Randomised Trial Comparing Intravitreal Bevacizumab With Laser Therapy in the Management of Diabetic Macular Oedema

M. Michaelides; R. Hamilton; A. Kaines; S. Fraser-Bell; C. Egan; T. Peto; P. Hykin

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4334.

ARVO Annual Meeting Abstract April 2009

Human Cone Anatomy in Macular Disease: Adaptive Optics Scanning Laser Ophthalmoscopic Imaging of Cones in Idiopathic Macular Telangectasia

S. D. Schwartz; A. Kaines; J. Duncan; B. Lujan; S. Sundquist; S. A; M. Sato; A. Roorda

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1656.

ARVO Annual Meeting Abstract April 2009

Correlation Between Adaptive Optics Scanning Laser Ophthalmoscopy and Spectral Domain Optical Coherence Tomography in Macular Telangiectasia

B. J. Lujan; P. F. Stetson; J. L. Duncan; A. Kaines; S. Sundquist; A. Soloyevev; M. Sato; S. D. Schwartz; A. Roorda

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1657.

ARVO Annual Meeting Abstract April 2009

Ultra Wide Field Fluorescein Angiography Guided Targeted Retinal Photocoagulation

S. Reddy; A. Kaines; A. Hu; S. D. Schwartz

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5268.

ARVO Annual Meeting Abstract May 2008

Diabetic Macular Oedema: A Prospective Randomised Trial of Management With Intravitreal Bevacizumab (avastin) versus Conventional Laser Therapy: A Description of Methodology

A. Kaines; S. Fraser-Bell; M. Michelaelides; C. Egan; P. Hykin

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3505.

Advertisement